Exogenous thyroxine improves glucose intolerance in insulin-resistant rats

Area of Science:

• Endocrinology
• Metabolic Research
• Molecular Biology

Background:

• Thyroid hormones (TH) play a role in glucose regulation, with both hypothyroidism and hyperthyroidism linked to glucose intolerance.
• The effects of TH on glucose metabolism in insulin-resistant states are not fully understood.
• TH derivatives are potential treatments for glucose intolerance and insulin resistance (IR).

Purpose of the Study:

• To investigate the effects of thyroxine (T4) on glucose intolerance and insulin resistance in a rat model.
• To elucidate the molecular mechanisms underlying T4's glucoregulatory effects in impaired metabolism.

Main Methods:

• Oral glucose tolerance tests (oGTT) were conducted on lean (LETO) and obese (OLETF) rats, with one OLETF group receiving T4 treatment for five weeks.
• Gene expression analysis was performed on skeletal muscle to assess key metabolic markers.
• Insulin signaling pathways, including AMPK and insulin receptor activation, were evaluated.

Main Results:

• T4 treatment significantly attenuated glucose intolerance by 15% and decreased the insulin resistance index (IRI) by 34% in OLETF rats.
• Despite a decrease in muscle Glut4 mRNA, T4 increased the expression of MCT10, DIO2, SIRT1, and UCP2.
• Improvements in glucose metabolism and insulin resistance were observed independently of significant changes in AMPK or insulin receptor activation.

Conclusions:

• T4 treatment enhances glucose homeostasis and insulin sensitivity in an obese rat model.
• The glucoregulatory effects of T4 appear to be mediated by increased intracellular T4 availability and subsequent upregulation of SIRT1 and UCP2 in skeletal muscle.
• These findings suggest T4 and its derivatives as potential therapeutic agents for metabolic disorders characterized by insulin resistance.